163 related articles for article (PubMed ID: 16924645)
1. Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
Aguilar C; Lucía JF
Am J Hematol; 2007 Mar; 82(3):246-7. PubMed ID: 16924645
[No Abstract] [Full Text] [Related]
2. Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia.
Wróbel G; Dobaczewski G; Patkowski D; Sokół A; Grotthus E
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):729-30. PubMed ID: 16933258
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant factor VII-a--new possibility for the treatment of severe postpartal bleeding--literature review].
Katsulov A; Getskovski T; Iankov M; Kirova N
Akush Ginekol (Sofiia); 2004; 43(5):44-6. PubMed ID: 15518285
[No Abstract] [Full Text] [Related]
4. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding.
Hirasaki Y; Suematsu Y; Yasuda T; Tajima K
Anesth Analg; 2010 Jan; 110(1):261-2. PubMed ID: 20023190
[No Abstract] [Full Text] [Related]
5. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
[TBL] [Abstract][Full Text] [Related]
6. [Application of recombinant activated factor VII in gynecological intervention (case report)].
Nacheva A; Gateva Zh; Atanasova V
Akush Ginekol (Sofiia); 2004; 43 Suppl 4():3-5. PubMed ID: 15673003
[No Abstract] [Full Text] [Related]
7. Successful use of recombinant factor VIIa in a patient with acquired Glanzmann thrombasthenia.
Tuffigo M; Lazaro E; James C; Subtil C; Viallard JF; Fiore M
Haemophilia; 2015 Jan; 21(1):e116-8. PubMed ID: 25471665
[No Abstract] [Full Text] [Related]
8. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
Hennewig U; Laws HJ; Eisert S; Göbel U
Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
[TBL] [Abstract][Full Text] [Related]
9. The use of recombinant-activated factor VII to successfully control postoperative critical bleeding after emergency repair of ruptured abdominal aortic aneurysm in a noncoagulopathic patient.
Dell'Utri D; Passariello M
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):570-2. PubMed ID: 16884992
[No Abstract] [Full Text] [Related]
10. Con: The role of recombinant factor VIIa in the control of bleeding after cardiac surgery.
Al-Ruzzeh S; Ibrahim K; Navia JL
J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):783-5. PubMed ID: 18922443
[No Abstract] [Full Text] [Related]
11. Thromboelastography-guided recombinant factor VIIa administration in a patient with refractory autoimmune idiopathic thrombocytopenia.
James KM; Melikian CN; Chowdary P; Mallett SV
Anesth Analg; 2008 Aug; 107(2):402-5. PubMed ID: 18633015
[TBL] [Abstract][Full Text] [Related]
12. [Activated recombinant factor VII for bleeding after a kidney transplant: reflections].
Pajares A; Larrea L
Rev Esp Anestesiol Reanim; 2006 Apr; 53(4):266-7; author reply 268. PubMed ID: 16711505
[No Abstract] [Full Text] [Related]
13. Recombinant activated factor VII in the management of massive obstetric bleeding.
Palomino MA; Chaparro MJ; de Elvira MJ; Curiel EB
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):226-7. PubMed ID: 16575264
[No Abstract] [Full Text] [Related]
14. Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients.
van de Garde EM; Bras LJ; Heijmen RH; Knibbe CA; van Dongen EP; Wiltink EH; Biesma DH
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):573-5. PubMed ID: 16884993
[No Abstract] [Full Text] [Related]
15. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M
Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305
[No Abstract] [Full Text] [Related]
16. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
Gielen-Wijffels SE; van Mook WN; Ramsay G
Ned Tijdschr Geneeskd; 2003 Mar; 147(9):419. PubMed ID: 12661464
[No Abstract] [Full Text] [Related]
17. Recombinant factor VIIa is a pan-hemostatic agent?
Aledort LM
Thromb Haemost; 2000 May; 83(5):637-8. PubMed ID: 10823252
[No Abstract] [Full Text] [Related]
18. Continuous infusion of recombinant factor VIIa: continue or not?
Ewenstein BM
Thromb Haemost; 2001 Oct; 86(4):942-4. PubMed ID: 11686349
[No Abstract] [Full Text] [Related]
19. The use of recombinant factor VIIa in severe postpartum hemorrhage.
Segal S; Shemesh IY; Blumental R; Yoffe B; Laufer N; Mankuta D; Mazor M; Zohar S; Schiff E; Martinovitz U
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):771-2. PubMed ID: 15255852
[No Abstract] [Full Text] [Related]
20. Caution with the use of recombinant activated factor VII in treating postoperative hemorrhage in cardiac surgery.
Al-Ruzzeh S; Mahmoud A; Shah S; O'Regan D
Ann Thorac Surg; 2007 Jan; 83(1):355; author reply 355-6. PubMed ID: 17184710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
